Guest guest Posted April 2, 2009 Report Share Posted April 2, 2009 Dear All; As I've tried to explain in recent postings, one possibility to account for PSC is that toxic bacterial products in the gut, such as endotoxin (lipopolysaccharide), are not adequately detoxified, and get through a " leaky gut " to be transported to the liver, where they cause inflammation. I've mentioned that there are three lines of defense against endotoxin: 1. Secreted IgA in the gut can bind to endotoxin. 2. Intestinal alkaline phosphatase can clip off a phosphate group from endotoxin, rendering it less toxic. 3. Bactericidal/permeability-increasing protein (BPI) can bind tightly to endotoxin, neutralizing it. Once the endotoxin breaches these defenses, it can bind to CD14, and then to Toll-like receptors (such as TLR4) triggering inflammation. Here I'd like to note that the vitamin A metabolite, retinoic acid, is involved in the regulation of ALL of these components. Retinoic acid increases IgA secretion in the gut: Kim CH (2008) Roles of retinoic acid in induction of immunity and immune tolerance. Endocr. Metab. Immune Disord. Drug Targets. 8: 289-294. Retinoic acid increases the expression of intestinal alkaline phosphatase (in participation with the thyroid hormone): Malo MS, Zhang W, Alkhoury F, Pushpakaran P, Abedrapo MA, Mozumder M, Fleming E, Siddique A, JW, Hodin RA (2004) Thyroid hormone positively regulates the enterocyte differentiation marker intestinal alkaline phosphatase gene via an atypical response element. Mol. Endocrinol. 18: 1941-1962. Retinoic acid increases the expression of the bactericidal/permeability-increasing protein (BPI): Lennartsson A, Vidovic K, Pass MB, Cowland JB, Gullberg U (2006)All-trans retinoic acid-induced expression of bactericidal/permeability-increasing protein (BPI) in human myeloid cells correlates to binding of C/EBPbeta and C/EBPepsilon to the BPI promoter. J. Leukoc. Biol. 80: 196-203. Retinoic acid reduces gut permeability/leakiness: Osanai M, Nishikiori N, Murata M, Chiba H, Kojima T, Sawada N (2007) Cellular retinoic acid bioavailability determines epithelial integrity: role of retinoic acid receptor alpha agonists in colitis. Mol. Pharmacol. 71: 250-258. Retinoic acid decreases expression of CD14, and to a lesser extent, TLR4: Liu PT, Krutzik SR, Kim J, Modlin RL (2005) Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function. J. Immunol. 174: 2467-2470. So retinoic acid (a derivative of vitamin A) seems to be intimately involved in this pathway. But, as I've also mentioned, vitamin A is not the only dietary constituent that can affect these processes. Omega-3 fatty acids found in fish oils can also act to reduce gut permeability/leakiness: Jiang WG, Bryce RP, Horrobin DF, Mansel RE (1998) Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids. Biochem. Biophys. Res. Commun. 244: 414-420. Usami M, Muraki K, Iwamoto M, Ohata A, Matsushita E, Miki A (2001) Effect of eicosapentaenoic acid (EPA) on tight junction permeability in intestinal monolayer cells. Clin. Nutr. 20: 351-359. And the micronutrient zinc is essential for intestinal alkaline phosphatase activity: Bortolato M, Besson F, Roux B (1999) Role of metal ions on the secondary and quaternary structure of alkaline phosphatase from bovine intestinal mucosa. Proteins 37: 310-328. My son takes fish oils and a Centrum Silver vitamin supplement which contains vitamin A, vitamin D, and zinc, to name but a few of the ingredients. I might add that a lot of my reading in this area is due to the fact that my son first presented with PSC in conjunction with acne, which is often treated with retinoic acid: __________________________ J. Immunol. 174: 2467-2470 (2005) Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function. Liu PT, Krutzik SR, Kim J, Modlin RL. Department of Microbiology, Immunology and Molecular Genetics, Geffen School of Medicine at University of California, Los Angeles, USA. A major consequence of microbial infection is the tissue injury that results from the host inflammatory response. In acne, inflammation is due in part to the ability of Propionibacterium acnes to activate TLR2. Because all-trans retinoic acid (ATRA) decreases inflammation in acne, we investigated whether it regulates TLR2 expression and function. Treatment of primary human monocytes with ATRA led to the down-regulation of TLR2 as well as its coreceptor CD14, but not TLR1 or TLR4. The ability of a TLR2/1 ligand to trigger monocyte cytokine release was inhibited by pre- and cotreatment with ATRA; however, TLR4 activation was affected by cotreatment only. ATRA also down-regulated monocyte cytokine induction by P. acnes. These data indicate that ATRA exerts an anti-inflammatory effect on monocytes via two pathways, one specifically affecting TLR2/1 and CD14 expression and one independent of TLR expression. Agents that target TLR expression and function represent a novel strategy to treat inflammation in humans. PMID: 15728448 __________________________ I might also add that since taking fish oils together with Centrum Silver, urosdiol and rifampin, his acne has improved dramatically. Best regards. Dave (father of (23); PSC 07/03; UC 08/03) Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.